Who owns VanEck Pharmaceutical ETF?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of PPH from SEC Form 13F filings across 155 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 155 institutions disclosed 6.5M shares of VanEck Pharmaceutical ETF worth $709.6M — about 74.6% of shares outstanding; the largest disclosed holder is MORGAN STANLEY. Source: SEC Form 13F filings, parsed by EvidInvest.
155
13F holders
$709.6M
value, 2026 filers
74.6%
of shares outstanding (6.5M sh)
24
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of PPH's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | MORGAN STANLEY | 1.2M | $130.9M | 0.0% | 13.8% | +16.3% |
| 2 | GOLDMAN SACHS GROUP INC | 1.2M | $130.4M | 0.0% | 13.7% | +1.0% |
| 3 | BANK OF AMERICA CORP /DE/ | 445,354 | $48.8M | 0.0% | 5.1% | +458.8% |
| 4 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 402,000 | $44.0M | 0.1% | 4.6% | 0.0% |
| 5 | J.Safra Asset Management Corp | 328,313 | $35.9M | 1.6% | 3.8% | +2.7% |
| 6 | UBS Group AG | 315,892 | $34.6M | 0.0% | 3.6% | -39.0% |
| 7 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 270,159 | $29.6M | 0.0% | 3.1% | -4.1% |
| 8 | Avalon Trust Co | 254,155 | $27.8M | 1.7% | 2.9% | -3.7% |
| 9 | WELLINGTON MANAGEMENT GROUP LLPNEW | 203,768 | $22.3M | 0.0% | 2.3% | new |
| 10 | BNP PARIBAS FINANCIAL MARKETS | 152,264 | $16.7M | 0.0% | 1.8% | -56.6% |
| 11 | LPL Financial LLC | 151,572 | $16.6M | 0.0% | 1.7% | +28.4% |
| 12 | CITIGROUP INC | 118,466 | $13.0M | 0.0% | 1.4% | -62.8% |
| 13 | ROYAL BANK OF CANADA | 116,926 | $12.8M | 0.0% | 1.3% | +22.5% |
| 14 | ADAMSBROWN WEALTH CONSULTANTS LLC | 101,704 | $11.1M | 2.0% | 1.2% | -34.0% |
| 15 | Miller Investment Management, LP | 101,256 | $11.1M | 1.0% | 1.2% | +1.0% |
| 16 | TUDOR INVESTMENT CORP ET AL | 97,993 | $10.7M | 0.0% | 1.1% | +1146.7% |
| 17 | OLD NATIONAL BANCORP /IN/NEW | 72,448 | $7.9M | 0.2% | 0.8% | new |
| 18 | Rye Brook Capital LLC | 70,255 | $7.7M | 5.0% | 0.8% | +4.3% |
| 19 | WT Wealth Management | 47,796 | $5.2M | 1.5% | 0.6% | -11.1% |
| 20 | CITADEL ADVISORS LLC | 40,537 | $4.4M | 0.0% | 0.5% | +22.2% |
| 21 | Cetera Investment Advisers | 39,704 | $4.3M | 0.0% | 0.5% | +9.4% |
| 22 | Prime Capital Investment Advisors, LLC | 38,493 | $4.2M | 0.0% | 0.4% | -9.4% |
| 23 | Tower Research Capital LLC (TRC) | 33,395 | $3.7M | 0.0% | 0.4% | +6.5% |
| 24 | Fortis Group Advisors, LLCNEW | 31,593 | $3.8M | 0.6% | 0.4% | new |
| 25 | Fluent Financial, LLC | 26,901 | $2.9M | 1.0% | 0.3% | -31.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation. Research, not investment advice.